Eppendorf AG and the Science journal are now accepting applications for the Eppendorf & Science Prize for Neurobiology 2017. The annual, international prize comes with a bourse of EUR 23,000 and goes to young scientists for outstanding contributions to neurobiological research based on methods of molecular and cell biology. Researchers aged up to 35 years have until June 15, 2017 to submit their entries. A panel of independent experts headed by Dr. Peter Stern, Science Senior Editor, will select the finalists and prize-winner.
Reproducing the development of the human brain
Last year’s prize went to Dr. Gilad Evrony, an Israeli-American scientist, who is conducting research at New York’s Mount Sinai Hospital. Dr. Evrony is developing technologies to sequence and analyse the genomes of single cells from the human brain. His research has uncovered a diversity of mutations in neuronal genomes indicating that every neuron in the brain carries a unique fingerprint of somatic mutations. Such mutations can cause focal brain malformations and may play a role in other unsolved neurologic diseases. The technology also allows, for the first time, reconstruction of developmental lineage trees in the human brain to study how cells proliferate and migrate to build the brain.
Subsidiaries in 25 countries
Eppendorf AG, a leading life science company, develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. The product range includes pipettes, dispensers and centrifuges, mixers and reaction vessels. The company manufactures ultra-low temperature freezers, bioreactors, CO2 incubators, shakers and DNA amplification equipment. Eppendorf’s products are used in academic and industrial research laboratories in the pharmaceutical, biotech, chemical and food industries. Founded in Hamburg in 1945, Eppendorf AG now employs 3,000 staff in branches across 25 countries.